Free Trial
NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

LifeMD logo
$5.46 -2.06 (-27.39%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$5.50 +0.04 (+0.82%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LifeMD Stock (NASDAQ:LFMD)

Key Stats

Today's Range
$5.41
$7.55
50-Day Range
$4.72
$8.28
52-Week Range
$3.99
$12.88
Volume
4.66 million shs
Average Volume
899,505 shs
Market Capitalization
$236.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.14
Consensus Rating
Moderate Buy

Company Overview

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

LFMD MarketRank™: 

LifeMD scored higher than 31% of companies evaluated by MarketBeat, and ranked 785th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeMD has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    LifeMD has only been the subject of 3 research reports in the past 90 days.

  • Read more about LifeMD's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeMD are expected to grow in the coming year, from ($0.56) to $0.12 per share.

  • Price to Book Value per Share Ratio

    LifeMD has a P/B Ratio of 36.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeMD's valuation and earnings.
  • Percentage of Shares Shorted

    14.19% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 5.04%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LifeMD does not currently pay a dividend.

  • Dividend Growth

    LifeMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.19% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 5.04%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for LifeMD this week, compared to 2 articles on an average week.
  • Search Interest

    17 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 70% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added LifeMD to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeMD insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $670,250.00 in company stock.

  • Percentage Held by Insiders

    15.97% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.52% of the stock of LifeMD is held by institutions.

  • Read more about LifeMD's insider trading history.
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Stock News Headlines

Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
Craig-Hallum Sticks to Its Buy Rating for LifeMD (LFMD)
LifeMD initiated with a Neutral at Mizuho
See More Headlines

LFMD Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $4.95 on January 1st, 2025. Since then, LFMD stock has increased by 10.3% and is now trading at $5.46.
View the best growth stocks for 2025 here
.

LifeMD, Inc. (NASDAQ:LFMD) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($0.14) earnings per share for the quarter, missing analysts' consensus estimates of ($0.09) by $0.05. The business earned $53.39 million during the quarter, compared to analyst estimates of $53.53 million.

Top institutional shareholders of LifeMD include Royce & Associates LP (2.58%), Connor Clark & Lunn Investment Management Ltd. (2.15%), Millennium Management LLC (2.05%) and Geode Capital Management LLC (1.90%). Insiders that own company stock include Justin Schreiber, Bertrand Velge, Naveen Bhatia, Nicholas P Alvarez, Eric Harold Yecies, Stefan Galluppi and Joseph Ditrolio.
View institutional ownership trends
.

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeMD investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
11/07/2024
Today
2/22/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.14
High Stock Price Target
$15.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+104.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-11.15%

Debt

Sales & Book Value

Annual Sales
$152.55 million
Book Value
$0.15 per share

Miscellaneous

Free Float
36,395,000
Market Cap
$236.47 million
Optionable
Optionable
Beta
1.50
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:LFMD) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners